PDF下载 ( 2607 KB)
A181 site mutation in HBV reverse transcriptase region on chronic HBV-infected patients during Entecavir therapy
-
摘要: 目的探讨恩替卡韦与HBV逆转录酶区单独A181位点突变的关系。方法对5例应用恩替卡韦治疗后逆转录酶区出现单独A181位点突变的慢性HBV感染者做回顾性调查与随访,并分析其突变前后病毒学指标的变化。结果 5例应用恩替卡韦治疗的慢性HBV感染者中,3例发生逆转录酶区A181V突变的病例均对恩替卡韦产生了应答,2例发生逆转录酶区A181T突变的病例血清HBV DNA也出现了明显下降。结论 5例应用恩替卡韦治疗的慢性HBV感染者逆转录酶区的单独A181位点的突变为自然产生,HBV逆转录酶区发生自然突变的临床意义需要进一步明确。Abstract: Objective To explore the relationship between A181 site mutation in HBV reverse transcriptase(rt) region(rtA181V) and Entecavir therapy on chronic HBV-infected patients.Methods Five chronic HBV-infected patients with only A181 site mutation during Entecavir treatment were reviewed retrospectively and followed.Virological and biochemical response were analyzed pre-and post-mutation.Results From the total of 5 patients,3 responded well to the treatment,and the serum level of HBV DNA declined significantly in 2 of the 3 patients.Conclusion The A181 site mutation in HBV reverse transcriptase of 5 patients may be a spontaneous mutation.The significance of natural mutation in the HBV reverse transcriptase region needs to be identified.
-
Key words:
- hepatitis B /
- chronic /
- hepatitis B virus /
- point mutation /
- genes
-
[1]中华医学会.病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62. [2]Kay A,Zoulim F.Hepatitis B virus genetic variability and evolution[J].J Virusres,2007,127(2):164-176. [3]梁雪松,万谟彬.核苷(酸)类似物长期治疗的常见耐药位点及发生率[J].中华肝脏病杂志,2007,15(1):55-56. [4]徐东平,李进,张玲霞.恩替卡韦治疗慢性乙型肝炎的研究进展[J].中华医学杂志,2006,86(28):2014-2016. [5] Xiong S.乙型肝炎病毒耐药性研究进展[J].肝脏,2006,11(4):273-275. [6]Villet S,Pichoud C,Billioud G,et al.Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure[J].J Hepatol,2008,48(5):747-755. [7]Warner N,Locarnini S.The antiviral drug selected hepatitis B virus rtA181T/sW172*mutant has a dominant negative secretion defect and alters the typical profile of viral rebound[J].Hepatology,2008,48(1):88-98. -
本文二维码
计量
- 文章访问数: 3511
- HTML全文浏览量: 24
- PDF下载量: 868
- 被引次数: 0
下载:
